BridgeBio Pharma Stock Earns 87 RS Rating

YAHOO FINANCE CHARTBOOK

44 charts that explain markets and the economy right now

BridgeBio Pharma Stock Earns 87 RS Rating

BridgeBio Pharma Stock Earns 87 RS Rating · Investor's Business Daily

INVESTOR'S BUSINESS DAILY and JULIE MAK

Tue, Jan 14, 2025, 1:30 PM 1 min read

In This Article:

BridgeBio Pharma stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an increase from 64 to 87. Is BridgeBio Pharma Stock A Buy? BridgeBio Pharma earns the No. 180 rank among its peers in the Medical-Biomed/Biotech industry group.

Terms and Privacy Policy

Your Privacy Choices

Utah Privacy Notice